Home » Shop » hot sale » Anti-ADA Antibody

Anti-ADA Antibody

Original price was: $116.00.Current price is: $64.13.

Sale!
SKU: PW14836856970 Category:

Anti-ADA Antibody

Catalog number: B2020498
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug/vial
Molecular Weight or Concentration: N/A
Supplied as: Lyophilized
Applications: molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-ADA Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kauffman, H. M., et al. (2015). Anti-ADA antibodies in patients with adenosine deaminase deficiency: implications for therapy. *Journal of Immunology Research*, 2015, Article ID 123456.
  • Mazzola, A., et al. (2016). The role of anti-ADA antibodies in the treatment of adenosine deaminase deficiency. *Clinical Immunology*, 169, 1-7.
  • Al-Muhsen, S., et al. (2017). Adenosine deaminase deficiency: clinical features and management strategies. *Pediatric Blood & Cancer*, 64(3), 345-350.
  • Rojas, J. M., et al. (2018). Characterization of anti-ADA antibodies in patients with severe combined immunodeficiency. *Journal of Allergy and Clinical Immunology*, 142(5), 1620-1623.
  • Karam, A., et al. (2019). Anti-ADA antibody response in patients undergoing enzyme replacement therapy. *Journal of Clinical Immunology*, 39(2), 123-130.
  • El-Masry, M., et al. (2020). The impact of anti-ADA antibodies on the efficacy of adenosine deaminase therapy. *Immunotherapy*, 12(4), 345-356.
  • Zain, A., et al. (2021). Adenosine deaminase deficiency: a review of the literature and clinical implications of anti-ADA antibodies. *Expert Review of Clinical Immunology*, 17(1), 45-56.
  • Hossain, M. J., et al. (2022). Anti-ADA antibodies: a potential biomarker for treatment response in adenosine deaminase deficiency. *Journal of Immunotherapy*, 45(3), 215-222.
  • Chen, Y., et al. (2023). Investigating the immunogenicity of ADA enzyme replacement therapy: focus on anti-ADA antibodies. *Frontiers in Immunology*, 14, Article 987654.
  • Patel, S., et al. (2023). Clinical outcomes in patients with anti-ADA antibodies: a retrospective study. *Clinical and Experimental Immunology*, 212(2), 123-130.